13F

Stock

Neurocrine Biosciences Inc

NBIX · held by 7 managers

Reported value

$49.1M

Holders

7

+0 new · −1 exited

Holders’ est. mark

$4.75M

Price effect on 5 books still in the name

Largest holder

$24.3M

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC178.4K$24.3M$3.8MAdded$3.42M
PKO BP BANKOWY Universal Pension Society JSC128.8K$17.6MHeld
DANSKE BANK A/S40.9K$5.58M$870.7KCut−$4.1M
Swiss Life Asset Management Ltd10.4K$1.42M$76.9KAdded$995.4K
Leonteq Securities AG842$114.9K$11.2KAdded$54.6K
Prestige Wealth Management Group LLC44$6.01K$532Added$3.13K
Aventura Private Wealth, LLC39$5.32KHeld

Who left

Positions as of Q4 2024. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.